A recent study highlights how fear and stigma significantly impact women's decisions to undergo cervical cancer screening and follow through with treatment. Many women fear receiving a negative diagnosis, especially if they perceive cancer as fatal or a financial burden. The anticipation of community stigma also plays a role in their reluctance.
According to this study by a team of researchers from the University of Nairobi and other institutions titled, “Fear, stigma, and Health system constraints shaping Cervical Cancer screening and treatment linkage in Kenya,” highlights how emotional and social factors, combined with health system weaknesses, create a challenging landscape for the cervical cancer care in the country.
The study found that effective after screening is a critical, yet fragile, stage. Issues like inadequate essential screening supplies, slow result reporting, staff shortages, and the need to pay for services are major hurdles in effective screening and cancer care for women in Kenya.
Timely communication of results, coordinated services, and strong support from healthcare providers, family, and the community were recommended to greatly improve Kenyan women’s journey through diagnosis and treatment.
To improve the cervical cancer care in Kenya, policymakers were urged to ensure a steady supply of screening materials, adequate staffing, and efficient laboratory processing.
The study recommended streamlined integrated health systems that connect screening, counseling, and treatment, thereby reducing logistical and financial hurdles for patients. Training healthcare providers on screening guidelines, clear communication, and patient privacy is also vital for building trust and encouraging screening.
Utilizing community health workers and social support systems was also recommended to further help normalize screening and support women throughout their treatment.
- Log in to post comments
